| Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells BA Mangan, MR Dunne, VP O’Reilly, PJ Dunne, MA Exley, D O’Shea, ... The Journal of Immunology 191 (1), 30-34, 2013 | 179 | 2013 |
| Persistent Changes in Circulating and Intestinal gamma delta T Cell Subsets, Invariant Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Children and Adults … M DUNNE, D DOHERTY | 131 | 2013 |
| Changes in human dendritic cell number and function in severe obesity may contribute to increased susceptibility to viral infection D O'Shea, M Corrigan, MR Dunne, R Jackson, C Woods, G Gaoatswe, ... International Journal of Obesity, 2013 | 87 | 2013 |
| Coeliac disease pathogenesis: the uncertainties of a well-known immune mediated disorder MR Dunne, G Byrne, FG Chirdo, C Feighery Frontiers in Immunology 11, 513850, 2020 | 70 | 2020 |
| (E)-4-Hydroxy-3-methyl-but-2 enyl pyrophosphate-stimulated Vγ9Vδ2 T cells possess T helper type 1-promoting adjuvant activity for human monocyte-derived … MR Dunne, L Madrigal-Estebas, LM Tobin, DG Doherty Cancer immunology, immunotherapy 59, 1109-1120, 2010 | 57 | 2010 |
| Mucosal-associated invariant T cells display diminished effector capacity in oesophageal adenocarcinoma AM Melo, AM O'Brien, JJ Phelan, SA Kennedy, NAW Wood, N Veerapen, ... Frontiers in immunology 10, 1580, 2019 | 52 | 2019 |
| Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide AE Hogan, V O'Reilly, MR Dunne, RT Dere, SG Zeng, C O'Brien, S Amu, ... Clinical Immunology 140 (2), 196-207, 2011 | 45 | 2011 |
| Effects of a multimodal rehabilitation programme on inflammation and oxidative stress in oesophageal cancer survivors: the ReStOre feasibility study EM Guinan, SL Doyle, L O’Neill, MR Dunne, EK Foley, J O’Sullivan, ... Supportive Care in Cancer 25, 749-756, 2017 | 44 | 2017 |
| Obesity-associated cancer: an immunological perspective RJV Conroy MJ, Dunne MR, Donohoe CL Proceedings of the Nutrition Society, 1-14, 2015 | 42* | 2015 |
| Preferential Th1 Cytokine Profile of Phosphoantigen-Stimulated Human Vgamma9Vdelta2 T Cells M DUNNE, B MANGAN, D MADRIGAL-ESTEBAS LAURA, DOHERTY Mediators of Inflammation 2010 (Article ID 704941), 2010 | 42 | 2010 |
| Enhanced angiogenic function in response to fibroblasts from psoriatic arthritis synovium compared to rheumatoid arthritis S Fromm, CC Cunningham, MR Dunne, DJ Veale, U Fearon, SM Wade Arthritis research & therapy 21, 1-11, 2019 | 40 | 2019 |
| HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients MR Dunne, AJ Michielsen, KE O’Sullivan, MC Cathcart, R Feighery, ... Cancer Immunology, Immunotherapy 66, 841-850, 2017 | 38 | 2017 |
| Interleukin‐17 producing mucosal associated invariant T cells‐emerging players in chronic inflammatory diseases? MM Pisarska, MR Dunne, D O'Shea, AE Hogan European Journal of Immunology 50 (8), 1098-1108, 2020 | 28 | 2020 |
| Enrichment of Inflammatory IL-17 and TNF-α Secreting CD4+ T Cells within Colorectal Tumors despite the Presence of Elevated CD39+ T Regulatory Cells and … MR Dunne, C Ryan, B Nolan, M Tosetto, R Geraghty, DC Winter, ... Frontiers in Oncology 6, 50, 2016 | 28 | 2016 |
| Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma AM Buckley, N Lynam-Lennon, SA Kennedy, MR Dunne, JJ Aird, ... Oncotarget 9 (72), 33634-33647, 2018 | 26 | 2018 |
| Characterising the prognostic potential of HLA-DR during colorectal cancer development MR Dunne, JJ Phelan, AJ Michielsen, AA Maguire, C Dunne, P Martin, ... Cancer Immunology, Immunotherapy 69, 1577-1588, 2020 | 25 | 2020 |
| The tumour immune microenvironment in oesophageal cancer M Davern, NE Donlon, R Power, C Hayes, R King, MR Dunne, ... British Journal of Cancer 125 (4), 479-494, 2021 | 24 | 2021 |
| Pyrazinib (P3),[(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinoma AM Buckley, MR Dunne, N Lynam-Lennon, SA Kennedy, A Cannon, ... Cancer letters 447, 115-129, 2019 | 22 | 2019 |
| The cancer-immune set point in oesophageal cancer R Power, MA Lowery, JV Reynolds, MR Dunne Frontiers in Oncology 10, 891, 2020 | 21 | 2020 |
| CD3ε expression defines functionally distinct subsets of Vδ1 T cells in patients with human immunodeficiency virus infection PJ Dunne, CO Maher, M Freeley, K Dunne, A Petrasca, J Orikiiriza, ... Frontiers in immunology 9, 940, 2018 | 20 | 2018 |
Joanne LysaghtTrinity College DublinVerified email at tcd.ie
